S797-119

Introduced

To amend title 5, United States Code, to protect and expand access to fertility treatment under the health insurance program carried out under chapter 89 of that title, and for other purposes.

119th Congress Introduced Feb 27, 2025

Legislative Progress

Introduced
Introduced Committee Passed
Feb 27, 2025

Ms. Duckworth (for herself, Mr. Welch, Ms. Warren, Mr. Padilla, …

Summary

What This Bill Does

This bill requires all health insurance plans offered to federal employees through the Federal Employees Health Benefits (FEHB) program to cover fertility treatments. The coverage must include in vitro fertilization (IVF), egg and sperm freezing, artificial insemination, genetic testing of embryos, fertility medications, and gamete (egg/sperm) donation. The bill takes effect one year after passage.

Who Benefits and How

Federal employees and their dependents who need fertility treatment are the primary beneficiaries - they will have insurance coverage for expensive procedures like IVF that currently cost tens of thousands of dollars out-of-pocket. The fertility treatment industry also benefits significantly: fertility clinics, IVF providers, pharmaceutical companies selling fertility medications, genetic testing laboratories, sperm and egg banks, and cryopreservation facilities will all see increased revenue as federal employees can now use their insurance to pay for these services.

Who Bears the Burden and How

Health insurance companies that provide FEHB plans must expand their coverage to include all fertility treatments, which increases their costs and administrative complexity. The federal government, as the employer, will face higher health insurance premium costs since it shares the cost of FEHB coverage with employees. The Office of Personnel Management (OPM) will need to coordinate with the Department of Health and Human Services to implement the new requirements and potentially expand the definition of covered services.

Key Provisions

  • Mandates coverage of IVF and other assisted reproductive technologies for all FEHB plans
  • Requires coverage of egg, sperm, and embryo freezing for future reproductive use
  • Includes all forms of artificial insemination (intravaginal, intracervical, and intrauterine)
  • Covers genetic testing of embryos and fertility medications (both prescription and over-the-counter)
  • Grants the OPM Director authority to expand the definition of covered fertility services in coordination with HHS
  • Takes effect one year after the bill becomes law
Model: claude-opus-4-5-20251101
Generated: Dec 24, 2025 05:36

Evidence Chain:

This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.

Primary Purpose

Expand and mandate fertility treatment coverage under the Federal Employees Health Benefits (FEHB) program

Policy Domains

Healthcare Employee Benefits Reproductive Health

Legislative Strategy

"Mandate comprehensive fertility treatment coverage for federal employees by expanding statutory benefits definition"

Likely Beneficiaries

  • Federal employees and their dependents seeking fertility treatment
  • Fertility clinics and reproductive endocrinologists
  • IVF service providers
  • Pharmaceutical companies producing fertility medications
  • Genetic testing laboratories
  • Gamete donation services

Likely Burden Bearers

  • Federal employee health insurance carriers (required to cover new services)
  • U.S. Treasury (increased federal employee health benefit costs)
  • Office of Personnel Management (implementation and coordination requirements)

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Employee Benefits Reproductive Health
Actor Mappings
"the_director"
→ Director of the Office of Personnel Management
"the_secretary"
→ Secretary of Health and Human Services

Key Definitions

Terms defined in this bill

1 term
"fertility treatment" §2(c)

Includes preservation of oocytes/sperm/embryos, artificial insemination, assisted reproductive technology (IVF), genetic testing of embryos, fertility medications, gamete donation, and other related services as determined by OPM Director in coordination with HHS Secretary

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology